Real-World Treatment Patterns and Healthcare Costs in Patients with Psoriatic Arthritis Treated with Ixekizumab: A Retrospective Study.

Murage, Mwangi J; Princic, Nicole; Park, Julie; Malatestinic, William; Zhu, Baojin; Atiya, Bilal; Kern, Scott A; Stenger, Keri B; Sprabery, Aubrey Trevelin; Ogdie, Alexis

Murage, Mwangi J; Princic, Nicole; Park, Julie; Malatestinic, William; Zhu, Baojin; Atiya, Bilal; Kern, Scott A; Stenger, Keri B; Sprabery, Aubrey Trevelin; Ogdie, Alexis.

Afiliación

Murage MJ; Eli Lilly and Company, Indianapolis, Indiana.
Princic N; IBM Watson Health, Cambridge, Massachusetts.
Park J; IBM Watson Health, Cambridge, Massachusetts.
Malatestinic W; Eli Lilly and Company, Indianapolis, Indiana.
Zhu B; Eli Lilly and Company, Indianapolis, Indiana.
Atiya B; Eli Lilly and Company, Indianapolis, Indiana.
Kern SA; Eli Lilly and Company, Indianapolis, Indiana.
Stenger KB; Eli Lilly and Company, Indianapolis, Indiana.
Sprabery AT; Eli Lilly and Company, Indianapolis, Indiana.
Ogdie A; Hospital of the University of Pennsylvania, Philadelphia.

ACR Open Rheumatol ; 3(12): 879-887, 2021 Dec.

Article en En | MEDLINE | ID: mdl-34550647

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Observational_studies / Prognostic_studies Idioma: En Revista: ACR Open Rheumatol Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google